Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations

Wataru Kubo, Shozo Miyazaki, David Attwood

    Research output: Contribution to journalArticlepeer-review

    Abstract

    The purpose of this study was to evaluate the potential for the oral sustained delivery of paracetamol of two formulations with in situ gelling properties. Oral administration of aqueous solutions of either gellan gum (1.0%, w/v) or sodium alginate (1.5%, w/v) containing calcium ions in complexed form resulted in the formation of gel depots in rabbit and rat stomachs as a consequence of the release of the calcium ions in the acidic environment. In vitro studies demonstrated diffusion-controlled release of paracetamol from the gels over a period of 6h. The bioavailability of paracetamol from the gels formed in situ in the stomachs of rabbits following oral administration of the liquid formulations was similar to that of a commercially available suspension containing an identical dose of paracetamol. © 2003 Elsevier Science B.V. All rights reserved.
    Original languageEnglish
    Pages (from-to)55-64
    Number of pages9
    JournalInternational Journal of Pharmaceutics
    Volume258
    Issue number1-2
    DOIs
    Publication statusPublished - 4 Jun 2003

    Keywords

    • Alginate gels
    • Gellan gels
    • In situ gelation
    • Oral drug delivery
    • Paracetamol
    • Sustained release

    Fingerprint

    Dive into the research topics of 'Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations'. Together they form a unique fingerprint.

    Cite this